POINTE-CLAIRE, QC, July 6, 2022 /CNW Telbec/ – MedHelper Inc., a Canadian healthcare expertise firm, is proud to announce their choice within the 4th Name of the FSISSS program for his or her challenge “Implementation of a digital platform to extend therapeutic adherence through an interactive patient-healthcare skilled mannequin”.
“The challenge goals to judge the platform effectiveness at enhancing adherence, an vital subject in environment friendly healthcare. It’s estimated that greater than 1.3 million Quebecers don’t adhere to their therapy as prescribed. By making certain higher therapy efficacy and persistent illness management, improved adherence has the potential to supply a number of advantages equivalent to lowered co-morbidities, lowered prices related to hospitalizations, lowered absenteeism from work, and optimization of well being care companies on the whole.”, stated Terry Fitzpatrick, Co-founder and CEO, MedHelper Inc.
The FSISSS program offers monetary assist for the implementation and analysis of progressive tasks in actual healthcare settings. An vital lever put in place as a part of the 2017-2022 Quebec Life Sciences Technique, the FSISSS program goals to reply to urgent well being challenges and reveal worth to establishments in Quebec’s public well being and social companies community.
The Quebec Authorities introduced its plans to speed up improvements in well being and social companies in a latest press launch. A full checklist of FSISSS tasks coated by this announcement (4th and fifth Calls) could be discovered right here.
MedHelper is the chief in offering post-diagnostic assist for folks taking drugs. The Montreal primarily based healthcare expertise start-up focuses on digitizing personalised care plans to make them extra accessible. The answer encourages higher care plan execution, builds stronger relationships and communication between people and their healthcare suppliers.
For extra info go to https://medhelper.com/.
For additional info: Meighen Fitzpatrick, T: 5149756849, Electronic mail: [email protected]